Previous studies have hinted at the down‐regulation of FGF1 and FGF9, indicating a weakened antioxidant capacity in DN, rendering the kidney susceptible to oxidative stress injury [44]. The gene discussed is FGF1; the disease is liver dysplastic nodule.